Digital therapeutics is SaMD(Software as a Medical Device) that employs high quality softwareto treat patients
Core Competencies
Analysis
Our analysts differentiate development strategy by focusing on medical unmet needs
R & D
Our physicians and scientists research and develop evidence-based solutions
SW Development
Our team develops captivating programs in compliance with industry regulations and standards
Clinical Validation
Our priority is to prove its efficacy and safety in collaboration with top notch institutions
BIXINK strives to be a pioneer in developing Korea's first FDA-approved digital therapeutics, and is currently pursuing pilot study in the United States
